Results 131 to 140 of about 57,449 (202)

Preparation of Buprenorphine Sublingual Tablets and Clinical Effects.

, 1994
Michiteru Ohtani, Hajime Kotaki, Fuminori Shibuya, Kenji Nishitateno, Yasufumi Sawada, Tatsuji Iga   +5 more
openalex   +2 more sources

Comparison of Extended-Release Buprenorphine Doses for Treating High-Risk Opioid Use: A Randomized Clinical Trial.

JAMA Netw Open
Shiwach R, Le Foll B, Alho H, Dunn KE, Strafford S, Zhao Y, Dobbins RL.   +6 more
europepmc   +1 more source

Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance Database. [PDF]

Brain Sci
Chiappini S, Orsolini L, Corkery JM, Guirguis A, Mosca A, Arillotta D, Martinotti G, Schifano F.   +7 more
europepmc   +1 more source

Reduced need for inpatient care following introduction of long-acting injectable buprenorphine. [PDF]

BMC Health Serv Res
Gauffin E, Marques Franca A, Pizzaro Ferrero E, Freij Z, Pihlflyckt I, Sandell M, Gedeon C, Zhang H, Andersson D, Tinghög G, Johansson Capusan A.   +10 more
europepmc   +1 more source

Trends in Initiation of Buprenorphine for Opioid Use Disorder Among Older Adults. [PDF]

J Am Geriatr Soc
Mayrer BM, Sabol RM, Shuey B, Roy PJ, Suda KJ, Park TW, Anderson TS.   +6 more
europepmc   +1 more source

Multi-level barriers and facilitators to buprenorphine use in Ontario, Canada: a qualitative study using the theoretical domains framework. [PDF]

Addict Sci Clin Pract
Leece P, Khorasheh T, Zerger S, Corace K, Nixon L, Strike C, Bayomi AM, Marks E, Holowaty M, Crichlow F, Taha S, Straus SE.   +11 more
europepmc   +1 more source

Influence of residential greenness and season on discontinuation of medication treatment for opioid use disorder across rural to urban community types. [PDF]

Addict Behav Rep
Poulsen MN, Nordberg CM, Bandeen-Roche K, DeWalle J, Berrettini W, Schwartz BS.   +5 more
europepmc   +1 more source

Psychometric evaluation of the opiate dosage adequacy scale: reliability and convergent validity among non-European Spanish-speaking buprenorphine patients. [PDF]

Front Psychiatry
Flores Ocasio T, Rivera NM, Duconge J, Venkataramanan R, González-Saiz F, Santiago D.   +5 more
europepmc   +1 more source

<i>Kappa</i>-opioid receptor gene (<i>OPRK1</i>) variations associated with opioid abstinence behaviors among chronic heroin users. [PDF]

Front Pharmacol
Greenwald MK, Demery C, Moses TEH, Burmeister M.   +3 more
europepmc   +1 more source

Statewide Prehospital Buprenorphine in Delaware: Two-Years of Paramedic-Initiated Medication for Opioid Use Disorder After Overdose. [PDF]

Dela J Public Health
Wanner GK, Dworkin M, Rosenbaum RA.
europepmc   +1 more source